ROVATI, GIANENRICO
 Distribuzione geografica
Continente #
EU - Europa 7.911
NA - Nord America 7.200
AS - Asia 6.649
SA - Sud America 755
AF - Africa 120
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.694
Nazione #
US - Stati Uniti d'America 7.017
GB - Regno Unito 2.299
CN - Cina 2.083
SG - Singapore 1.978
IT - Italia 1.382
DE - Germania 1.249
RU - Federazione Russa 695
HK - Hong Kong 666
SE - Svezia 633
BR - Brasile 578
VN - Vietnam 434
FR - Francia 339
IN - India 322
TR - Turchia 322
NL - Olanda 284
KR - Corea 229
IE - Irlanda 224
UA - Ucraina 209
FI - Finlandia 188
BD - Bangladesh 173
CA - Canada 118
EU - Europa 114
ID - Indonesia 102
JP - Giappone 100
DK - Danimarca 78
CO - Colombia 54
PL - Polonia 48
MX - Messico 46
BE - Belgio 45
AU - Australia 42
GR - Grecia 42
AR - Argentina 41
ES - Italia 41
AT - Austria 34
IQ - Iraq 33
CH - Svizzera 31
ZA - Sudafrica 29
EC - Ecuador 25
PH - Filippine 24
IL - Israele 21
SA - Arabia Saudita 20
TH - Thailandia 18
CI - Costa d'Avorio 17
CL - Cile 17
EG - Egitto 15
PT - Portogallo 15
UZ - Uzbekistan 14
TW - Taiwan 13
MA - Marocco 12
NZ - Nuova Zelanda 12
PK - Pakistan 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
NO - Norvegia 11
MY - Malesia 10
PY - Paraguay 10
VE - Venezuela 10
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
KE - Kenya 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
HU - Ungheria 7
LT - Lituania 7
PE - Perù 7
UY - Uruguay 7
BG - Bulgaria 6
KZ - Kazakistan 6
NP - Nepal 6
ET - Etiopia 5
MD - Moldavia 5
RS - Serbia 5
SC - Seychelles 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
JM - Giamaica 4
KH - Cambogia 4
LB - Libano 4
LU - Lussemburgo 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
KG - Kirghizistan 3
OM - Oman 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
NA - Namibia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
Totale 22.781
Città #
Southend 1.996
Singapore 1.141
Ashburn 703
Hong Kong 623
Milan 557
Chandler 499
San Jose 420
Beijing 417
Seattle 314
Princeton 280
Santa Clara 254
Dallas 250
Wilmington 247
Hanover 234
Council Bluffs 226
Dublin 219
Ann Arbor 214
Los Angeles 196
Fairfield 167
Redmond 149
Munich 147
Woodbridge 141
Nanjing 140
Ho Chi Minh City 132
Jacksonville 132
Mountain View 120
Bengaluru 113
Lauterbourg 112
Buffalo 109
Des Moines 105
New York 102
Hanoi 101
Dearborn 98
Houston 89
Sakarya 88
Shanghai 87
Guangzhou 85
Andover 79
Frankfurt am Main 79
Serra 69
Cambridge 68
Moscow 68
Helsinki 66
Sunnyvale 65
Redwood City 63
Somerville 62
Grafing 59
Boardman 58
Jinan 58
Jakarta 52
São Paulo 51
Hefei 50
Shenyang 50
Columbus 49
Tokyo 47
Tianjin 46
Bogotá 45
The Dalles 44
Rome 41
Berlin 40
Athens 39
Brussels 39
Hangzhou 38
Fuzhou 37
Istanbul 36
Shenzhen 36
Cangzhou 35
Toronto 34
Phoenix 32
Changsha 30
Zhengzhou 29
Chicago 26
San Diego 26
Seoul 25
Turin 25
Warsaw 25
London 24
Roxbury 24
Nanchang 23
Nuremberg 23
Vienna 23
Naples 22
Montreal 21
Fremont 20
Orem 20
Da Nang 19
Falls Church 19
Wuhan 19
Eitensheim 18
Jiaxing 18
Medford 18
Ningbo 18
Atlanta 17
Haiphong 17
Hebei 17
Rio de Janeiro 17
Sydney 17
Abidjan 16
Boston 16
Brooklyn 16
Totale 13.290
Nome #
Design and characterization of superpotent bivalent ligands targeting oxytocin receptor dimers via a channel-like structure 706
The concise guide to pharmacology 2021/22 : G protein-coupled receptors 569
Current perspective on eicosanoids in asthma and allergic diseases - EAACI Task Force consensus report, part I 471
Impaired thromboxane receptor dimerization reduces signaling efficiency: a potential mechanism for reduced platelet function in vivo 459
Age-related decline in RACK-1 expression in human leukocytes is correlated to plasma levels of dehydroepiandrosterone 338
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen 331
Leukotriene D(4)-induced activation of smooth-muscle cells from human bronchi is partly Ca(2+)-independent 325
Reciprocal interference between the NRF2 and LPS signaling pathways on the immune-metabolic phenotype of peritoneal macrophages 325
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation 323
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor 306
The Concise Guide to Pharmacology 2019/20: G protein-coupled receptors 290
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology 285
Coinvolgimento di GPR17, un nuovo recettore duale per nucleotidi extracellulari e cistenil-leucotrieni, nell'ischemia cerebrale 277
Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor 260
Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and g protein activation 260
Thromboxane prostanoid receptor in human airway smooth muscle cells : a relevant role in proliferation 256
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation 254
CysLT(1) leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors 251
Developmental expression of heteromericnicotinic receptor subtypes in chick retina 245
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation 239
Montelukast Use Decreases Cardiovascular Events in Asthmatics 239
Antagonism of thromboxane receptors by diclofenac and lumiracoxib 233
A role for inflammatory mediators in heterologous desensitization of CysLT(1) receptor in human monocytes 232
Aspetti quantitativi e qualitativi dell'interazione farmaco-recettore 231
Expression of prostacyclin receptors in luteinizing hormone-releasing hormone immortalized neurons: role in the control of hormone secretion 229
CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras 228
Cysteinyl-leukotrienes in the regulation of Beta2-Adrenoceptor function: an in vitro model of asthma 228
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: signaling through the CysLT2 receptor 226
Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies 224
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain 215
Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells 214
CysLT1 receptor is a target for extracellular nucleotides-induced heterologous desensitization : a possible feed-back mechanism in inflammation 214
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain 206
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. 205
Thromboxane prostanoid receptor signals through Gi protein to rapidly activate ERK in human airways 200
Gpr17 modulators, method of screening and uses thereof 199
Cysteinyl-leukotriene receptor antagonists : present situation and future opportunities 198
Pharmacogenetics of the g protein-coupled receptors 198
Montelukast inhibits TNFalpha-mediated IL-8 expression through inhibition of NF-kappa B p65-associated histone acetyltransferase activity 196
A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C-4 binding site not coupled to contraction in human lung parenchyma 196
Cys-leukotriene inhibitors also inhibit P2Y receptor-mediated signaling 193
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile 192
Farmaci per il sistema respiratorio 189
Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat 187
Heterotrimeric G proteins demonstrate differential sensitivity to beta-arrestin dependent desensitization 183
HETEROGENEITY OF BINDING-SITES FOR ICI-198,615 IN HUMAN LUNG PARENCHYMA 181
Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling 179
Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade 179
International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor 176
EICOSANOID RELEASE AND MEPYRAMINE, LTC4 AND LTD4 BINDING IN PASSIVELY SENSITIZED HUMAN LUNG PARENCHYMA INVITRO 175
Receptors for cysteinyl-leukotrienes in human cells 172
Oligomerization of thromboxane A2 receptor : from computational modelling to biochemistry 171
Eicosanoids and Their Drugs in Cardiovascular Diseases : Focus on Atherosclerosis and Stroke 170
Two distinct P2Y receptors are involved in purine- and pyrimidine-evoked Ca2+ elevation in mammalian brain astrocytic cultures 170
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends 169
Cys-leukotriene receptors, their antagonists and transduction mechanism in human airways 169
The lipoxin receptor ALX : potent ligand-specific and stereoselective actions in vivo 167
Transcellular biosynthesis of eicosanoid lipid mediators 166
A potential role of PUFAs and COXIBs in cancer chemoprevention 166
Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk 166
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition 165
Dual COXIB/TP antagonists : a possible new twist in NSAID pharmacology and cardiovascular risk 164
Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects 164
Evaluation of the pharmacological activity of the pure cysteinyl-leukotriene receptor antagonists CGP 45715a (iralukast) and CGP 57698 in human airways 164
Leukotrienes in asthma pathophysiology 164
Montelukast inhibits platelet activation induced by plasma from COVID-19 patients 164
Membro della Commmissione IUPHAR per la Nomenclatura dei Recettori per i Leucotrieni e le Lipossine 161
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective 159
4-oxystilbene compounds are selective ligands for neuronal nicotinic alpha Bungarotoxin receptors 158
Physiological Features of the Neural Stem Cells Obtained from an Animal Model of Spinal Muscular Atrophy and Their Response to Antioxidant Curcumin 156
Binding of leukotriene C4 to human lung membranes 156
Pharmacological characterization of 2NTX-99, a potential antiatherothrombotic agent with antithromboxane and no-donor activity 150
Leukotriene receptor antagonists in the treatment of allergic rhinitis 149
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors 149
Binding to cysteinyl-leukotriene receptors 149
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 148
Drug-receptor interactions : quantitative and qualitative aspects 148
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 146
ADENOSINE A(1) RECEPTORS IN RAT-BRAIN SYNAPTOSOMES - TRANSDUCTIONAL MECHANISMS, EFFECTS ON GLUTAMATE RELEASE, AND PRESERVATION AFTER METABOLIC INHIBITION 146
Leukotriene receptors 146
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19 146
EFFECTS OF LORATADINE ON CYTOSOLIC CA2+ LEVELS AND LEUKOTRIENE RELEASE - NOVEL MECHANISMS OF ACTION INDEPENDENT OF THE ANTIHISTAMINE ACTIVITY 143
Functional Characterization of E. coli LptC: Interaction with LPS and a Synthetic Ligand 143
A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate 142
Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants 142
Cross-talk Between Cysteinyl-Leukotriene and Purinergic Receptors 142
IDENTIFICATION OF SPECIFIC BINDING-SITES FOR LEUKOTRIENE-C4 IN MEMBRANES FROM HUMAN-LUNG 141
Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma 139
AN ALTERNATIVE MODEL FOR BELL-SHAPED CONCENTRATION-RESPONSE CURVES - REPLY 139
A selective antagonist for the neuronal alpha7 nAChR subtype 139
Cysteinyl-leukotriene receptors and cellular signals 138
Imaging the daily life of the G protein-coupled thromboxane A2 receptor : from dimerization to internalization 138
Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents 137
Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC4 and LTD4 in human lung parenchyma 135
Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis 135
The highly conserved DRY motif of class A G protein-coupled receptors : beyond the ground state 132
Light on the structure of thromboxane A₂ receptor heterodimers 132
Functional variants of the cysteinyl leukotriene 1 and cysteinyl leukotriene 2 receptors are associated with atopic asthma 131
PROSTACYCLIN LIPOPROTEIN INTERACTIONS - STUDIES ON HUMAN-PLATELET AGGREGATION AND ADENYLATE-CYCLASE 130
Interazioni Farmaco-recettore e risposta quantitativa ai farmaci 130
Totale 20.461
Categoria #
all - tutte 62.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 0 0 0 0 0 342 121
2021/20222.159 159 88 54 128 274 211 211 157 163 203 192 319
2022/20231.828 254 168 172 219 189 394 36 109 165 24 68 30
2023/20241.090 35 89 67 63 330 55 47 56 38 67 83 160
2024/20253.528 128 274 61 384 365 139 117 335 238 267 499 721
2025/20266.425 717 378 815 501 701 492 796 353 632 535 505 0
Totale 23.843